Insider · CIK 0001641300

Tenenbaum Fabian

Reports to the SEC for 1 company · WARREN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001641300

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-11-15	Bellerophon Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−76.8K sh	$0.34	−$26.1K	407,459
2019-09-26	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.75M sh	—	—	5,440,697
2019-05-21	Bellerophon Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$0.59	+$2,975	484,282
2019-01-02	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+12.5K sh	—	—	3,688,697
2018-11-20	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.49M sh	—	—	3,676,197
2018-09-25	Bellerophon Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+224K sh	—	—	479,282
2018-06-12	Bellerophon Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−63.5K sh	$2.37	−$150K	254,983
2018-01-12	Bellerophon Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+55.4K sh	—	—	318,469
2018-01-12	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+550K sh	—	—	550,000
2017-03-16	Bellerophon Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+120K sh	—	—	263,050
2016-12-07	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.04M sh	—	—	1,042,556
2016-11-29	Bellerophon Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+143K sh	—	—	142,857
2016-11-29	Bellerophon Therapeutics, Inc.Common Stock Warrants (right to buy)P Purchase	Director, Chief Executive Officer	PPurchase	+143K sh	—	—	142,857
2016-11-11	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+466K sh	—	—	466,141
2016-02-29	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+130K sh	—	—	130,000

Recent filings

Accepted (ET)
Nov 194
Tenenbaum Fabian0001600132-19-000160
SEC(opens sec.gov)
Sep 304
Tenenbaum Fabian0001600132-19-000131
SEC(opens sec.gov)
May 224
Tenenbaum Fabian0001600132-19-000084
SEC(opens sec.gov)
Jan 44
Tenenbaum Fabian0001600132-19-000015
SEC(opens sec.gov)
Nov 234
Tenenbaum Fabian0001600132-18-000179
SEC(opens sec.gov)
Sep 274
Tenenbaum Fabian0001600132-18-000143
SEC(opens sec.gov)
Jun 144
Tenenbaum Fabian0001600132-18-000076
SEC(opens sec.gov)
Jan 174
Tenenbaum Fabian0001600132-18-000023
SEC(opens sec.gov)
Mar 204
Bellerophon Therapeutics, Inc.0001600132-17-000028
SEC(opens sec.gov)
Dec 94
Bellerophon Therapeutics, Inc.0001628280-16-021955
SEC(opens sec.gov)
Dec 14
Bellerophon Therapeutics, Inc.0001628280-16-021746
SEC(opens sec.gov)
Nov 154
Bellerophon Therapeutics, Inc.0001571049-16-019927
SEC(opens sec.gov)
Mar 14
Bellerophon Therapeutics, Inc.0001600132-16-000019
SEC(opens sec.gov)

Companies

Bellerophon Therapeutics, Inc.Director, Chief Executive Officer

Address

184 LIBERTY CORNER ROAD SUITE 302

WARREN, NJ, 07059